AbstractThe reaction of the ruthenium arene dimers [(η6-arene)Ru(μ-Cl)Cl]2(where arene=benzene orp-cymene) with the ligands 4-benzylidene-3,5-di(2′-pyridyl)-4-amino-1,2,4-triazole (L1), 2-methoxybenzylidene-3,5-di(2′-pyridyl)-4-amino-1,2,4-triazole (L2), 4-methylbenzylidene-3,5-di(2′-pyridyl)-4-amino-1,2,4-triazole (L3) and indole-3-carbaldehyde-3,5-di(2′-pyridyl)-4-amino-1,2,4-triazole (L4) in a 1:2 ratio gives the new complexes [(η6-arene)RuCl(L)]+[arene=C6H6(with L=L1(1), L2(3), L4(7), with PF6−as a counter ion, and L4(6), with Cl−as a counter ion) orp-cymene with L=L1(2), L2(4), L3(5), L4(8) with PF6−as a counter ion]. All complexes were fully characterized using1H and13C NMR, elemental analyses, UV/Vis and IR spectroscopy. The single crystal X-ray structures of ligandL2and complex1have been determined. The structure of1has the Ru atom coordinated with the arene group and to theN,N′-bidentate ligand and to the Cl atom. The arene group occupies the apex, while the ligand and the Cl atom are at the base of a pseudo-octahedral three-legged piano stool. The cytotoxicity of these mononuclear complexes was established in the human epithelial colorectal adenocarcinoma cell line (Caco-2) and for selectivity in the non-cancerous human embryonic kidney cell line (HEK293), using 5-fluorouracil (5-FU) as the reference anticancer drug. Compounds1and7were relatively inactive toward the Caco-2 tumor cells (IC50>200), while complexes2–5showed moderate anti-proliferative properties (IC50>100–200). Compound6, however, displayed better anti-proliferative properties with an IC50value lower than that of the reference drug, 5-FU, and was therefore further investigated for its antimicrobial activity against six Gram-positive and four Gram-negative bacteria.
Towards Light‐Activated Ruthenium–Arene (RAPTA‐Type) Prodrug Candidates